We investigated the effect of the expression of seven biomarkers (ERCC1, BRAC1, RRM1, RRM2, P53R2, TUBB3, and TS) on survival in stages I–III NSCLC patients treated with surgery alone. This evidence concerns the gene TYMS and non-small cell lung carcinoma.